CANTEL MEDICAL CORP.
                               150 CLOVE ROAD
                       LITTLE FALLS, NEW JERSEY 07424
                               (973) 890-7220

FOR IMMEDIATE RELEASE
- ---------------------

Contact:  Cameron Associates, Inc., New York
          Richard E. Moyer
          Phone: 212-554-5466
          richard@cameronassoc.com
          ------------------------

                CANTEL ANNOUNCES CLOSING OF MINNTECH MERGER

     Little Falls, N.J.--September 7, 2001-- Cantel Medical Corp. (Nasdaq
NM:CNTL) today announced that it has completed the closing of its merger
transaction with Minntech Corporation. Pursuant to the terms of the merger
agreement Minntech shareholders are entitled to receive $6.25 in cash and
 .2216 of a share of Cantel common stock for each share of Minntech common
stock they own. In addition, Dr. Fred Shapiro, a nationally recognized
nephrologist and co-founder of Minntech, has become a member of the board
of directors of Cantel.

     Cantel and Minntech held simultaneous shareholders meetings on
Thursday, September 6, 2001. At the Cantel meeting Cantel's shareholders
approved the issuance of Cantel common stock in connection with the merger.
At the Minntech meeting Minntech's shareholders approved the merger
agreement and the merger.

     American Stock Transfer & Trust Company is acting as exchange agent
for Cantel and will send instructions to Minntech shareholders regarding
the procedure for surrendering their shares of Minntech common stock in
exchange for the merger consideration. Cantel shareholders need take no
action as a result of the merger.

     Cantel Medical Corp. is a healthcare company concentrating primarily
in infection prevention and control products and diagnostic and therapeutic
medical equipment. Through its United States subsidiary, MediVators, Inc.,
Cantel serves customers worldwide by designing, developing, manufacturing,
marketing and distributing innovative products for the infection prevention
and control industry. Through its Canadian subsidiary, Carsen Group Inc.,
Cantel markets and distributes medical equipment (including flexible and
rigid endoscopes), precision instruments (including microscopes and high
performance image analysis hardware and software) and industrial equipment
(including remote visual inspection devices). Cantel's subsidiaries also
provide technical maintenance services for their own products, as well as
for certain competitors' products.

     Minntech Corporation, utilizing its proprietary core technologies in
chemicals, hollow fibers, and electronics, has developed and currently
markets a wide variety of medical device reprocessing and fluid filtration
and separation products for the renal dialysis, medical device
disinfection, cardiosurgery, pharmaceutical, biotechnology and
semiconductor industries. Minntech is a world leader in renal dialyzer
reprocessing, providing a broad product line that includes a reprocessing
system and a sterilant that each command the largest market share in the
U.S. in their respective categories. Over the years, Minntech has been
granted over 155 patents on medical technologies, with 87 patent
applications pending.